Department of Pharmacology, Dalhousie University, Halifax, Canada.
Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, Canada.
BMC Oral Health. 2023 Apr 6;23(1):206. doi: 10.1186/s12903-023-02911-5.
A growing body of research associates the oral microbiome and oral cancer. Well-characterized clinical samples with outcome data are required to establish relevant associations between the microbiota and disease. The objective of this study was to characterize the community variations and the functional implications of the microbiome in low-grade oral epithelial dysplasia (OED) using 16S rRNA gene sequencing from annotated archival swabs in progressing (P) and non-progressing (NP) OED. We characterised the microbial community in 90 OED samples - 30 swabs from low-grade OED that progressed to cancer (cases) and 60 swabs from low-grade OED that did not progress after a minimum of 5 years of follow up (matched control subjects). There were small but significant differences between P and NP samples in terms of alpha diversity as well as beta diversity in conjunction with other clinical factors such as age and smoking status for both taxa and functional predictions. Across all samples, the most abundant genus was Streptococcus, followed by Haemophilus, Rothia, and Neisseria. Taxa and predicted functions were identified that were significantly differentially abundant with progression status (all Ps and NPs), when samples were grouped broadly by the number of years between sampling and progression or in specific time to progression for Ps only. However, these differentially abundant features were typically present only at low abundances. For example, Campylobacter was present in slightly higher abundance in Ps (1.72%) than NPs (1.41%) and this difference was significant when Ps were grouped by time to progression. Furthermore, several of the significantly differentially abundant functions were linked to the Campylobacteraceae family in Ps and may justify further investigation. Larger cohort studies to further explore the microbiome as a potential biomarker of risk in OED are warranted.
越来越多的研究将口腔微生物组与口腔癌联系起来。需要有特征明确的临床样本和结局数据,才能确定微生物组与疾病之间的相关关联。本研究的目的是使用从进展性(P)和非进展性(NP)低级别口腔上皮异型增生(OED)的标注存档拭子中进行 16S rRNA 基因测序,来描述微生物组在低级别口腔上皮异型增生(OED)中的群落变化及其功能意义。我们对 90 个 OED 样本中的微生物群落进行了描述,这些样本包括 30 个来自低级别 OED 的样本,这些样本在进展为癌症时(病例)进行了取样,以及 60 个来自低级别 OED 的样本,这些样本在经过至少 5 年的随访后没有进展(匹配对照)。在α多样性和β多样性方面,P 和 NP 样本之间存在较小但有统计学意义的差异,同时还存在其他临床因素,如年龄和吸烟状况,这些因素对分类群和功能预测都有影响。在所有样本中,最丰富的属是链球菌属,其次是嗜血杆菌属、罗氏菌属和奈瑟菌属。在所有样本中,丰度差异最大的属是链球菌属,其次是嗜血杆菌属、罗氏菌属和奈瑟菌属。根据采样和进展之间的时间长短或仅针对 P 样本的特定时间进展来对样本进行广泛分组时,我们发现了一些与进展状态显著相关的分类群和预测功能(所有的 P 和 NP)。然而,这些丰度差异显著的特征通常只存在于低丰度水平。例如,弯曲杆菌属在 P 样本中的丰度(1.72%)略高于 NP 样本(1.41%),当按时间进展对 P 样本进行分组时,这种差异具有统计学意义。此外,一些丰度差异显著的功能与 P 样本中的弯曲杆菌科家族有关,这可能值得进一步研究。需要更大的队列研究来进一步探索微生物组作为 OED 风险的潜在生物标志物。